349 related articles for article (PubMed ID: 32318847)
1. Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
Mamidipalli A; Fowler KJ; Hamilton G; Wolfson T; Covarrubias Y; Tran C; Fazeli S; Wiens CN; McMillan A; Artz NS; Funk LM; Campos GM; Greenberg JA; Gamst A; Middleton MS; Schwimmer JB; Reeder SB; Sirlin CB
Eur Radiol; 2020 Sep; 30(9):5120-5129. PubMed ID: 32318847
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes.
Fazeli Dehkordy S; Fowler KJ; Mamidipalli A; Wolfson T; Hong CW; Covarrubias Y; Hooker JC; Sy EZ; Schlein AN; Cui JY; Gamst AC; Hamilton G; Reeder SB; Sirlin CB
Eur Radiol; 2019 May; 29(5):2474-2480. PubMed ID: 30547206
[TBL] [Abstract][Full Text] [Related]
3. Pilot study on longitudinal change in pancreatic proton density fat fraction during a weight-loss surgery program in adults with obesity.
Covarrubias Y; Fowler KJ; Mamidipalli A; Hamilton G; Wolfson T; Leinhard OD; Jacobsen G; Horgan S; Schwimmer JB; Reeder SB; Sirlin CB
J Magn Reson Imaging; 2019 Oct; 50(4):1092-1102. PubMed ID: 30701611
[TBL] [Abstract][Full Text] [Related]
4. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
[TBL] [Abstract][Full Text] [Related]
5. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
Wang K; Cunha GM; Hasenstab K; Henderson WC; Middleton MS; Cole SA; Umans JG; Ali T; Hsiao A; Sirlin CB
AJR Am J Roentgenol; 2023 Nov; 221(5):620-631. PubMed ID: 37466189
[No Abstract] [Full Text] [Related]
7. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
[TBL] [Abstract][Full Text] [Related]
8. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
Hong CW; Wolfson T; Sy EZ; Schlein AN; Hooker JC; Fazeli Dehkordy S; Hamilton G; Reeder SB; Loomba R; Sirlin CB
J Magn Reson Imaging; 2018 Apr; 47(4):988-994. PubMed ID: 28842937
[TBL] [Abstract][Full Text] [Related]
9. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
[TBL] [Abstract][Full Text] [Related]
10. Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI.
Colgan TJ; Van Pay AJ; Sharma SD; Mao L; Reeder SB
J Magn Reson Imaging; 2020 Feb; 51(2):407-414. PubMed ID: 31168893
[TBL] [Abstract][Full Text] [Related]
11. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.
Pooler BD; Wiens CN; McMillan A; Artz NS; Schlein A; Covarrubias Y; Hooker J; Schwimmer JB; Funk LM; Campos GM; Greenberg JA; Jacobsen G; Horgan S; Wolfson T; Gamst AC; Sirlin CB; Reeder SB
Radiology; 2019 Mar; 290(3):682-690. PubMed ID: 30561273
[TBL] [Abstract][Full Text] [Related]
13. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.
Haufe WM; Wolfson T; Hooker CA; Hooker JC; Covarrubias Y; Schlein AN; Hamilton G; Middleton MS; Angeles JE; Hernando D; Reeder SB; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2017 Dec; 46(6):1641-1647. PubMed ID: 28323377
[TBL] [Abstract][Full Text] [Related]
15. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
[TBL] [Abstract][Full Text] [Related]
16. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R
Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
18. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
[TBL] [Abstract][Full Text] [Related]
19. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
